MEGIN

MEGIN is a global neuroscience technology company based in Espoo, Finland, specializing in functional brain mapping through advanced magnetoencephalography (MEG) solutions. With a team of over 70 employees across the USA, UK, Finland, and Japan, MEGIN serves a diverse customer base that includes leading research institutions and clinical centers. The company holds approximately 80% of the global MEG market share and is recognized as a leader in this field. The flagship product, TRIUX™ neo, is a fourth-generation MEG system designed for non-invasive detection and visualization of brain function. This technology aids in diagnostics and treatment planning for neurological diseases by providing detailed functional brain maps. MEGIN also offers a full range of services for MEG lab establishment and operation, including hardware and software development, installation, maintenance, and customer training. The company collaborates with clinicians and researchers to enhance brain health care and expand the applications of MEG technology, including partnerships aimed at improving accessibility for neurodegenerative conditions.

• Employees 71